Nadav Kidron, President and CEO, 10% Owner at ORAMED PHARMACEUTICALS INC. (ORMP), sold 61 shares at $5.98 ($365) on 2018-07-10, disclosed to the SEC on 2018-07-12.
Open-market sale of $365 ORMP by President and CEO, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ORMP | SELL | 2021-08-11 | $4.4M | — | Filing → |
| ORMP | BUY | 2016-05-12 | $7K | — | Filing → |
| ORMP | BUY | 2015-05-12 | $4K | — | Filing → |